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Shabnam Akhter, W Dwayne Lawrence and M Ruhul Quddus*Abstract
A 45 year old woman underwent Laparoscopy-assisted total hysterectomy with staging procedure following a
diagnosis of endometrial endometrioid adenocarcinoma on her endometrial biopsy. The hysterectomy specimen
showed a FIGO I stage 1a, endometrioid carcinoma. A separate polypoid lesion in the endometrium, distinct from the
carcinoma, was also identified. Microscopically the polypoid lesion was “nodular histiocytic hyperplasia”. The H&E,
immunohistochemical staining findings and the differential diagnoses are discussed in this report. Although
description of similar lesions is available in the literature, the current lesion is unique as it is identified in a
hysterectomy specimen in its entirety and its association with an endometrial endometrioid carcinoma.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1060511915121922
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Nodular histiocytic hyperplasia, initially thought to be of
mesothelial origin because of their sites of occurrences,
was reported in hernia sac [1]. Subsequently similar le-
sions have been reported from various other body sites,
e.g., the pericardial sacs and cardiac valves [2], periton-
eum [3] and pleura [4]. Their presence in endometrial
biopsy may mimic neoplasia. A recent series published
seven cases of nodular histiocytic hyperplasia [5]. The
cases, so far reported in the literature, are associated
with benign lesions only. Since the previously reported
cases were encountered in endometrial biopsies the le-
sions were fragmented. We report here a case of a nodu-
lar histiocytic hyperplasia associated with FIGO I/III
endometrial endometrioid adenocarcinoma. We also de-
scribe the lesion in its entirety; as noted above, all previ-
ous descriptions of this entity were based on their
presence in biopsy specimens.* Correspondence: mquddus@wihri.org
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A 45 year-old woman with a history of uterine fibroids
presented with vaginal bleeding. She was Gravida 1 and
Para 0, with a history of termination of pregnancy. A
pelvic ultrasound showed a 9.1 x 8.0 x 4.0 cm partially
distorted uterus with multiple hypoechoeic nodular
areas, the largest being 4 x 3 cm and a thickened,
1.8 cm, endometrial stripe.Pathologic findings
An endometrial biopsy revealed a FIGO I endometrial
endometrioid type adenocarcinoma. After weighing-in
all the options presented to her, the patient opted for a
Laparoscopy-assisted vaginal hysterectomy with bilateral
salpingo-oophorectomy and staging procedure.
Gross examination of the specimen revealed a 172
gms, 9.6 x 6.5 x 5.6 cm distorted uterus with multiple
subserosal and intramural fibroids. Upon opening the
uterus, a 4.5 x 4.2 cm shaggy polypoid lesion was identi-
fied in the endometrial cavity involving both uterine
walls. In addition a 0.7 x 0.5 cm polypoid lesion
(Figure 1a) was found on the anterior wall of the endo-
myometrium with smooth surface. The fibroids were
noted in the intramural and subserosal locations.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Photomicrographs of Nodular Histiocytic Hyperplasia. 1a (H&E): Low power magnification of polypoid nodular histiocytic
hyperplasia; 1b (H&E): Closely packed histiocytes near the base of the polyp; 1c (H&E): pink hyalinized fibrous bands separating aggregates of
histiocytes; 1d (H&E): thick-walled blood vessel mimicking “onion-skinning”; 1e (H&E): more sclerosis towards the surface of the polyp; 1f (IHC):
histiocytic immunohistochemistry marker (CD68) showing diffuse positivity; 1g (IHC): Pancytokeratin marker (AE1/AE3) is completely negative
(surface epithelium is reactive serving as positive internal control); 1h (IHC): HMB45 is negative.
Figure 2 Photomicrographs of Endometrioid adenocarcinoma arising in a background of secretory Endometrium. 2a (H&E): Low power view
of FIGO I endometrioid carcinoma; 2b (H&E): high power view of the same tumor; 2c (H&E): Carcinoma is arising in a background of secretory
endometrium.
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was found to consist mostly of aggregates of histiocytes
that were more closely packed near the endomyometrial
junction, i.e., the base of the lesion (Figure 1b). Pink hya-
linized fibrous bands are noted throughout the polypoid
lesion (Figure 1c). Many blood vessels with thickened
hyalinized walls are present throughout the lesion, more
commonly towards the surface (Figure 1d). Towards the
surface, the histiocytes were relatively sparse and sepa-
rated by sclerosis (Figure 1e). The polyp was lined by
a thin, attenuated, layer of endometrial epithelium
(Figure 1e). The histiocytes resembled perivascular epi-
thelioid cells. And presence of thick walled blood vessels
within the lesion raised the question of a perivascular
epithelioid cell tumor (PEComa). Immunohistochemical
stains reveal that the lesional cells are strongly and dif-
fusely reactive to a histiocytic marker, CD68, (Figure 1f )
and non-reactive to HMB45 (Figure 1h), pancytokeratin
(AE1/AE3), (1 g) Epithelial membrane antigen (EMA),
Desmin, Smooth Muscle Actin (SMA), CD10, Vimentin.
FIGO grade I stage 1a endometrioid adenocarcinoma
was noted in the endometrium as well (Figure 2a and
Figure 2b). The tumor involves areas of adenomyosis;
however, true myometrial invasion was not present. The
carcinoma was arising in background of functional endo-
metrium (Figure 2c). The lower uterine segment and
cervix were free of tumor. No lymph-vascular space in-
vasion was identified. The bilateral ovaries and fallopian
tubes were unremarkable. The regional lymph node dis-
section was all negative for metastatic carcinoma.
Discussion and conclusions
Nodular histiocytic hyperplasia is a rare lesion often inci-
dentally encountered in endometrial biopsies. Majority of
these lesions are reported in the literature as single case
report. The largest series, so far has been reported in the
literature, is based on 7 cases [5]. The lesion, when en-
countered in endometrial biopsies and present in small
fragments, may mimic a neoplasm. So far all the re-
ported cases are, however, associated with benign dis-
eases. The current report is based on a case of nodular
histiocytic hyperplasia associated with a FIGO I/III
endometrial endometrioid adenocarcinoma. The lesion
itself is identified grossly in its entirety as a distinct en-
tity presenting as an endometrial polyp.
The differential diagnoses of this entity include Lang-
erhans cell histiocytosis, xanthogranulomatous endomet-
ritis, malakoplakia, signet-ring cell changes of the
endometrial stromal cells, etc. Available reports in the
literature have elaborated how to distinguish nodular
histiocytic hyperplasia from their mimics. The current
case showed some resemblance with perivascular epithe-
lioid cell tumor (PEComa) or an epithelioid smooth
muscle tumor with many small hyalinized blood vessels.Microscopic and multifocal PEComa of the female geni-
tal tract have been reported [6,7]. One interesting find-
ing noted in the current case is the presence of
hyalinized fibrous strands throughout the lesion; a fea-
ture often seen in endometrial stromal tumors. The cyto-
logic appearance of the tumor cells seen in endometrial
stromal tumor is, however, completely different from
what was seen in nodular histiocytic hyperplasia. The
cells in endometrial stromal tumor are small, mostly
round and darkly stained, especially in low grade stro-
mal sarcoma.
Special stains that were performed to rule out the
mimics show the lesional cells of nodular histiocytic
hyperplasia are strongly and diffusely reactive to histio-
cytic marker, CD68. All other markers including, epithe-
lial markers (AE1/AE3), smooth muscle markers, and
endometrial stromal cell marker (CD10) were non-
reactive. HMB45, a marker for PEComa, was also
negative.
The site of nodular histiocytic hyperplasia was clearly
located on the surface of endometrium with smooth lin-
ing and protruding into the endometrial cavity.
It is speculated that the nodular histiocytic aggregates
may result from previous endometrial biopsy. The
current case did have a recent history of endometrial bi-
opsy one month prior to her hysterectomy. The previous
biopsy in this case revealed endometrial carcinoma with
squamous differentiation and no evidence of histiocytic
aggregate. It is also of note that the appearance of the
foamy histiocytes often seen in endometrial biopsies is
also different from the histiocytes present in nodular
hyperplasia as they lack the foamy cytoplasm.
Mazur and Kurman [8] proposed that these histiocytes
apparently reside in the endometrial cavity and reported
their presence in association with hydrometra and be-
nign bleeding patterns. The authors postulated that it
may represent a response to what they have proposed as
“intracavitary debris.” The current case was associated
with an endometrioid adenocarcinoma so presence of
some “intracavitary debris” is not unlikely. As noted be-
fore the polypoid lesion was seen projecting into the
endometrial cavity.
A possibly related, but morphologically dissimilar, his-
tiocytic endometrial lesion has been reported by Iezzoni
and Mills in their study of non-neoplastic endometrial
signet-ring cells [9]. No signet-ring cells are identified in
this case.
Kim et al. proposed that the endometrial stromal cells
showing progestational changes with atrophic endomet-
rial glands trapped in the middle may produce histologic
similarities that may vaguely resemble histiocytic aggre-
gate [10]. Unlike nodular histiocytic aggregate, decidua-
lized stromal cells do not form a discrete nodule. Kim
et al. also speculated that the nodules may not originate
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their cases [10]. The current case documents many blood
vessels in the nodule and thus contradicts that specula-
tion of Kim et al.
In conclusion, nodular histiocytic hyperplasia may not
always be associated with benign/inflammatory lesions
as previously reported in the literature. The current case
documents its association with endometrioid carcinoma
of the endometrium.
The patient is currently followed routinely and is dis-
ease free 80 months after surgery.
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